• Cy5 NHS ester(Et): Technical Guidance for Amino Group Labeli

  2026-07-08

  Cy5 NHS ester(Et) provides a high-purity, water-soluble solution for covalent fluorescent labeling of amino groups in proteins and other biomolecules, enabling sensitive detection in immunofluorescence staining, flow cytometry, and fluorescence microscopy workflows. It is not suitable for ethanol-based protocols or for long-term storage in solution, requiring prompt use after preparation. This guide offers actionable, evidence-based recommendations for practical laboratory use.

• HyperScript RT SuperMix for qPCR: Precision cDNA Synthesis

  2026-07-07

  HyperScript RT SuperMix for qPCR enables robust, reproducible cDNA synthesis for gene expression analysis, even from complex or low-abundance RNA. Its engineered reverse transcriptase supports high-temperature reactions, improving yield and fidelity. This article details biological rationale, mechanism, and evidence benchmarks for the APExBIO K1074 kit.

• ABT-737: BCL-2 Protein Inhibitor Workflows in Cancer & Senes

  2026-07-07

  ABT-737 stands out as a benchmark BCL-2 protein inhibitor, enabling precise apoptosis induction in cancer and senescence models. This guide translates the latest reference breakthroughs and real-world lab experience into actionable workflow upgrades and troubleshooting strategies.

• NFE2L1-DDI2-Proteasome Axis Shields Cells from Ferroptosis

  2026-07-06

  The referenced study uncovers how activation of the NFE2L1-ubiquitin-proteasome system (UPS) via DDI2 protects cells from ferroptosis, a form of regulated cell death. By dissecting the feedback loop between proteasome activity, NFE2L1 activation, and DDI2-mediated cleavage, the study identifies novel mechanistic targets for sensitizing cells to ferroptosis, with implications for cancer therapy and cellular stress research.

• CP-673451: Selective PDGFRα/β Inhibitor in Cancer Research

  2026-07-06

  CP-673451 sets a benchmark for selective PDGFRα/β inhibition, enabling precise dissection of PDGF-driven signaling in cancer models. Its nanomolar potency, kinase selectivity, and proven efficacy in complex tumor and angiogenesis assays—especially in ATRX-deficient contexts—make it an indispensable tool for translational research.

• Linoleic Acid (C18:2) for Oxidative Stress and Cell Assays

  2026-07-05

  Linoleic Acid (C18:2(9Z,12Z)), SKU C3108, enables reproducible modeling of oxidative stress, membrane fluidity, and essential fatty acid deficiency in cell-based and animal research. This compound is not suitable for workflows requiring long-term aqueous stock solutions or direct aqueous dosing. It is best applied where precise control of lipid environment and redox balance is essential.

• Hydrocortisone in Translational Oncology: From Barrier Defen

  2026-07-04

  Explore the role of hydrocortisone, a key glucocorticoid hormone, in translational oncology research. This article uncovers how hydrocortisone bridges inflammation models, barrier function, and cancer stemness, offering unique assay insights and evidence-based protocols.

• Metformin Hydrochloride: Mechanistic Insights and Protocols

  2026-07-03

  Explore the multifaceted mechanisms of Metformin Hydrochloride (Metformin HCl) in metabolic and bone research. This article uniquely integrates molecular pathways, translational insights, and detailed experimental parameters for researchers investigating glucose metabolism and heterotopic ossification.

• Ivermectin’s Role in Next-Gen Anti-Parasitic and Tumor Micro

  2026-07-03

  Explore how Ivermectin, a broad-spectrum anti-parasitic agent, is transforming both parasitology research and experimental oncology. This article delivers a deeper, protocol-driven analysis, highlighting unique assay considerations and translational insights not found in standard reviews.

• Arachidonic Acid: Optimizing Immunity and Inflammation Assay

  2026-07-02

  Arachidonic Acid (SKU C4223) empowers bench scientists to finely tune models of inflammation and immune modulation, with recent evidence linking dietary supplementation to enhanced vaccine antibody responses in both mice and humans. This guide translates cutting-edge findings into protocol enhancements and troubleshooting tips for eicosanoid, cyclooxygenase, and immune cell workflows.

• Translating Mouse IL-12 mRNA Into Next-Gen Immunotherapy Too

  2026-07-02

  This article explores how mechanistically engineered mRNA—specifically EZ Cap™ Mouse IL-12 mRNA (m1Ψ)—is reshaping translational immunotherapy research. We connect molecular insights, delivery innovations, and practical protocol guidance, drawing from recent advances in extrahepatic targeting and virus-mimetic nanoparticles. By integrating evidence from primary literature and comparative resources, this piece offers strategic advice for researchers seeking to unlock the full potential of cytokine mRNA in precision immune modulation.

• Optimizing Assays With Cell Counting Kit-8 (CCK-8) Plus

  2026-07-01

  Cell Counting Kit-8 (CCK-8) Plus provides a sensitive, rapid, and reproducible method for quantifying cell proliferation and cytotoxicity, especially where conventional tetrazolium salt assays fall short in sensitivity or linearity. It is ideal for routine cell viability, drug screening, and cytotoxicity assays, but should not be used where metabolic readouts are confounded by interfering compounds or non-reducing cell types.

• Gap26 Connexin 43 Mimetic Peptide: Optimizing Gap Junction R

  2026-07-01

  Gap26, a selective connexin 43 mimetic peptide, empowers researchers to dissect intercellular signaling with unmatched precision—enabling robust studies of calcium signaling, ATP release, and mitochondrial transfer. See how advanced workflows and troubleshooting strategies using Gap26 drive reproducibility and translational relevance in cardiovascular, neuroprotection, and inflammation research.

• Deferasirox Fe3+ chelate (A3355): Reliable Iron Chelation in

  2026-06-30

  This article guides biomedical researchers through real-world scenarios where Deferasirox Fe3+ chelate (SKU A3355) ensures reproducible, sensitive, and workflow-compatible solutions in cell viability and iron metabolism assays. By addressing practical challenges and integrating recent peer-reviewed evidence, we illustrate why APExBIO’s high-purity, DMSO-soluble Deferasirox Fe3+ chelate is a dependable choice for iron overload treatment research and beta-thalassemia models.

• Dual Recombinase Tracing Disproves Postnatal Neo-oogenesis i

  2026-06-30

  A recent study by Xie, Zhou, and Zheng introduces a dual recombinase-mediated genetic tracing system to rigorously test the existence of postnatal neo-oogenesis in mice. Their work provides compelling evidence that new oocyte generation does not occur after birth, even following ovarian injury, refining the foundational understanding and experimental modeling in mammalian reproductive biology.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page